PTIX · Protagenic Therapeutics, Inc.\new
$0.57
-0.17 (-22.97%)
At close · Jan 5
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not have sufficient resources to fund its operations past twelve months from the date these consolidated financial statements are available to be issued. The Company expects that additional capital may be required during the next 12 months to continue executing its business plan and to meet its obligations as they become due. Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.45M
Shares
1.81M
Protagenic Therapeutics, Inc.\new Earnings Call Transcripts
Quarterly earnings calls for Protagenic Therapeutics, Inc.\new (PTIX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.